Express Scripts Holding Company (NASDAQ:ESRX) was downgraded by investment analysts at UBS AG from a “market perform” rating to an “underperform” rating in a research note issued to investors on Monday.

A number of other equities analysts have also issued reports on the company. ValuEngine raised Express Scripts Holding from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. Royal Bank Of Canada assumed coverage on Express Scripts Holding in a research note on Tuesday, September 19th. They set a “sector perform” rating and a $68.00 price objective for the company. Robert W. Baird reissued a “hold” rating and set a $56.00 price objective on shares of Express Scripts Holding in a research note on Friday, September 1st. Jefferies Group LLC set a $72.00 price objective on Express Scripts Holding and gave the stock a “buy” rating in a research note on Tuesday, August 29th. Finally, Morgan Stanley raised their price objective on Express Scripts Holding from $52.00 to $57.00 and gave the stock an “underweight” rating in a research note on Thursday, August 10th. Five equities research analysts have rated the stock with a sell rating, eleven have given a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $69.45.

Shares of Express Scripts Holding (ESRX) opened at 62.36 on Monday. The firm’s 50-day moving average price is $62.27 and its 200-day moving average price is $62.66. The stock has a market capitalization of $36.02 billion, a P/E ratio of 10.82 and a beta of 0.88. Express Scripts Holding has a 52-week low of $57.80 and a 52-week high of $77.50.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.02. The firm had revenue of $25.35 billion during the quarter, compared to analyst estimates of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The firm’s quarterly revenue was up .5% on a year-over-year basis. During the same period last year, the company posted $1.57 EPS. Equities analysts forecast that Express Scripts Holding will post $6.99 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This story was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at https://www.thecerbatgem.com/2017/10/09/ubs-ag-lowers-express-scripts-holding-company-esrx-to-underperform.html.

In related news, VP Phyllis S. Anderson sold 578 shares of the stock in a transaction on Friday, September 8th. The stock was sold at an average price of $63.13, for a total transaction of $36,489.14. Following the completion of the sale, the vice president now directly owns 10,530 shares in the company, valued at $664,758.90. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Everett Neville sold 1,163 shares of the stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $61.48, for a total value of $71,501.24. Following the sale, the vice president now owns 18,232 shares of the company’s stock, valued at $1,120,903.36. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,641 shares of company stock valued at $357,317. 0.68% of the stock is owned by corporate insiders.

Several large investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Express Scripts Holding by 1.6% during the first quarter. Vanguard Group Inc. now owns 40,251,311 shares of the company’s stock worth $2,652,964,000 after acquiring an additional 649,400 shares in the last quarter. Dodge & Cox raised its holdings in shares of Express Scripts Holding by 25.7% during the second quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock worth $2,310,275,000 after acquiring an additional 7,388,021 shares in the last quarter. State Street Corp raised its holdings in shares of Express Scripts Holding by 1.1% during the first quarter. State Street Corp now owns 27,060,709 shares of the company’s stock worth $1,783,569,000 after acquiring an additional 298,341 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC raised its holdings in shares of Express Scripts Holding by 4.2% during the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 17,612,834 shares of the company’s stock worth $1,160,862,000 after acquiring an additional 704,218 shares in the last quarter. Finally, Macquarie Group Ltd. raised its holdings in shares of Express Scripts Holding by 8.4% during the second quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock worth $758,480,000 after acquiring an additional 922,406 shares in the last quarter. Institutional investors and hedge funds own 88.69% of the company’s stock.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.